Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
Luo W, Huang Z, Xu D, Yang M, Zhu Y, Shen L, Chen S, Tao X, Bin W, Hu Y, Franzblau SG, Jiang N, Wei Y, Wei X, Ding CZ.
Luo W, et al. Among authors: wei y, wei x.
Bioorg Med Chem Lett. 2022 Sep 15;72:128871. doi: 10.1016/j.bmcl.2022.128871. Epub 2022 Jun 28.
Bioorg Med Chem Lett. 2022.
PMID: 35777718